#long covid — Wednesday, July 08, 2026 (1 items)
| 0 | 💬 0 |
Efficacy and safety of rivaroxaban, colchicine, and famotidine-loratadine with specialist supportive clinical care for fatigue in patients with post-COVID-19 condition in the UK: a multisite, open-label, randomised controlled trial.
(linkinghub.elsevier.com)
|
Lancet Infectious Diseases 2026-07-08 | #long covid #fatigue #clinical trial #therapeutics |